ARTICLE | Financial News
Alexion slips as Street digests whistleblower allegations
November 12, 2016 12:14 AM UTC
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) slid $13.26 (10%) to $113.62 on Friday, reflecting continued investor concerns after the company on Wednesday said it was delaying its 3Q16 10-Q filing while it investigates a former employee’s allegations that company personnel engaged in sales practices "inconsistent" with Alexion's policies...
BCIQ Company Profiles